Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neoplasm Metastasis
Interventions: DRUG: Non pegylated liposomal doxorubicin and docetaxel
Sponsor: Catharina Ziekenhuis Eindhoven
Collaborators: Cephalon|Sanofi